Insulin-like growth factor (IGF)-I and IGF-binding protein-3 serum levels in relapsing-remitting and secondary progressive multiple sclerosis patients(540 views) Lanzillo R, Di Somma C, Quarantelli M, Ventrella G, Gasperi M, Prinster A, Vacca G, Pivonello C, Orefice G, Colao A, Morra VB
Keywords: Case-Control Study, Insulin-Like Growth Factor-Binding Protein-3, Multiple Sclerosis, Relapsing-Remitting, Secondary Progressive, Somatomedin Binding Protein 3, Adult, Article, Clinical Assessment Tool, Controlled Study, Disease Activity, Disease Course, Expanded Disability Status Scale, Female, Human, Major Clinical Study, Multiple Sclerosis Severity Scale, Priority Journal, Protein Blood Level, Secondary Progressive Multiple Sclerosis, Age Factors, Case-Control Studies, Insulin-Like Growth Factor Binding Protein 3, Middle Aged, Chronic Progressive, Severity Of Illness Index, Time Factors, Insulin-Like Growth Factor Binding Protein 3 Blood Physiology, Insulin-Like Growth Factor I Analysis Physiology, Chronic Progressive Blood Physiopathology, Relapsing-Remitting Blood Physiopathology,
Affiliations: *** IBB - CNR ***
Neurology, Hermitage Capodimonte Hospital, Naples, Italy
Department of Neurological Sciences, University 'Federico II', Naples, Italy
SDN Foundation, Naples, Italy
Biostructure and Bioimaging Institute, National Research Council, Naples, Italy
Department of Health Science, University of Molise, Contrada Tappino, Campobasso, Italy
Departments of Molecular and Clinical Endocrinology and Oncology, University 'Federico II', Naples, Italy
References: Not available.
Insulin-like growth factor (IGF)-I and IGF-binding protein-3 serum levels in relapsing-remitting and secondary progressive multiple sclerosis patients